CD4+ T cell recovery with antiretroviral therapy: more than the sum of the parts.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

14 citing papers in PubMed.

1. Enhanced IFN-γ, but not IL-2, response to Mycobacterium tuberculosis antigens in HIV/latent TB co-infected patients on long-term HAART.BMC immunology · 2019
   Article
2. Longitudinal Changes in Cd4Journal of fungi (Basel, Switzerland) · 2019
   Article
3. Immune Reconstitution Inflammatory Syndrome in HIV-Infected Immigrants.The American journal of tropical medicine and hygiene · 2017
   Article
4. CD4+ cells recovery in HIV positive patients with severe immunosuppression at HAART initiation at Centre Medico-Social Cor-Unum, Kigali.The Pan African medical journal · 2017
   Article
5. Non-initiation of hepatitis C virus antiviral therapy in patients with human immunodeficiency virus/hepatitis C virus co-infection.World journal of hepatology · 2016
   Article
6. Changes in coronary heart disease risk profiles of HIV patients in Zimbabwe over 9 months: a follow-up study.HIV/AIDS (Auckland, N.Z.) · 2016
   Article
7. Delayed reconstitution of B cell immunity to pneumococcus in HIV-infected Malawian children on antiretroviral therapy.The Journal of infection · 2015
   Article
8. CD4(+) T Cells Modified by the Endoribonuclease MazF Are Safe and Can Persist in SHIV-infected Rhesus Macaques.Molecular therapy. Nucleic acids · 2014
   Article
9. Novel cell and gene therapies for HIV.Cold Spring Harbor perspectives in medicine · 2012
   Review
10. Incidence and predictors of immune reconstitution inflammatory syndrome in a rural area of Mozambique.PloS one · 2011
    Article
11. Effectiveness of a 'hunter' virus in controlling human immunodeficiency virus type 1 infection.The Journal of general virology · 2010
    Article
12. Recent key advances in human immunodeficiency virus medicine and implications for China.AIDS research and therapy · 2010
    Article
13. Inhibition of envelope-mediated CD4+-T-cell depletion by human immunodeficiency virus attachment inhibitors.Antimicrobial agents and chemotherapy · 2009
    Article
14. The effects of setarud on the immunological status of HIV-positive patients: Efficacy of a novel multi-herbal drug.Avicenna journal of phytomedicine
    Article

Corrections and comments

• Comment on
  Incomplete reconstitution of T cell subsets on combination antiretroviral therapy in the AIDS Clinical Trials Group protocol 384.2009

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as